Related Experiment Video

Updated: Jun 28, 2026

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
07:42

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Published on: September 19, 2018

From immune response to cancer: a spot on the low molecular weight protein tyrosine phosphatase

A C S Souza1, S Azoubel, K C S Queiroz

  • 1Biochemistry Department, University of Campinas, UNICAMP, Campinas, SP, CEP: 13083-970, Brazil.

Cellular and Molecular Life Sciences : CMLS
|November 13, 2008
PubMed

Insights

The low molecular weight protein tyrosine phosphatase (LMWPTP) has a dual role in immunity and cancer. Understanding its regulation offers new therapeutic targets for inflammatory disorders and cancer.

Area of Science:

  • Biochemistry
  • Immunology
  • Oncology

Background:

  • Reversible tyrosine phosphorylation is a critical regulatory mechanism in eukaryotic cells.
  • Low molecular weight protein tyrosine phosphatase (LMWPTP) exhibits a dual role in immune responses.
  • Emerging evidence links LMWPTP to oncological processes.

Purpose of the Study:

  • To review the regulation of LMWPTP activity in immune cell signaling pathways.
  • To explore the association between LMWPTP genetic polymorphism and inflammatory disease predisposition.
  • To examine LMWPTP's contribution to cancer development, progression, and metastasis.

Main Methods:

  • Literature review focusing on LMWPTP's role in immunology and oncology.
  • Analysis of signaling pathways regulating LMWPTP enzymatic activity.
  • Examination of genetic studies on LMWPTP polymorphism and disease association.

Main Results:

  • LMWPTP modulates both appropriate and exaggerated immune responses.
  • Genetic variations in LMWPTP correlate with susceptibility to certain inflammatory conditions.
  • LMWPTP influences key aspects of cancer cell biology, including proliferation and migration.

Conclusions:

  • LMWPTP is a significant factor in immune regulation and cancer pathogenesis.
  • Targeting LMWPTP presents a promising strategy for treating inflammatory diseases and reducing cancer aggressiveness.

More Related Videos

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors08:45

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors

Published on: July 17, 2020

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...